We use cookies for a better user experience. Read our Privacy Policy
I Agree
Pediatric Health Care Products and Services Market
Global Pediatric Health Care Products and Services Market - Snapshot
Pediatrics is a branch of medicine which deals with the health, growth, and development of infants, children, and adolescents. According to the report, the global pediatric health care products and services market was valued at around US$ 88,000 Mn and US$ 520,000 Mn, respectively, in 2017 and is projected to expand at a CAGR of around 4.5% and 5.5%, respectively, from 2018 to 2026. Unhealthy lifestyle habits and rise in obese pediatric population propel the pediatric health care products and services market. The world is going through a rapid nutritional and epidemiological shift, rise in prevalence of obesity, cardiovascular disease, nutrition-related chronic diseases, and cancer. Changes in lifestyle, for instance, in eating habits, have led to an increase in obesity.
Obesity is a growing problem in developed as well as in developing countries. Obese or overweight children are likely to remain obese in their adulthood and are susceptible to non-communicable diseases, such as cardiovascular diseases and diabetes, at a younger age. According to a study conducted by the World Health Organization (WHO), in 2016 the number of overweight children, under the age of five, was estimated at more than 41 million globally. Almost half of all overweight children under five years of age lived in Asia and one quarter lived in Africa.
Launch of new drugs by pharmaceutical companies for pediatric patients and increase in focus by global research bodies on the development of new and improved drugs for children are expected to drive the pediatric therapeutics market during the forecast period. Rise in prevalence of diseases and disorders such as allergies, asthma, mental disorders, diabetes, infectious diseases among children and increase in awareness regarding these diseases among parents boost the pediatric services market. Rise in patient pool and increase in government efforts to raise awareness regarding pediatric disorders and treatments have created opportunities for players operating in the market.
The global pediatric health care products and services market has been analyzed based on drug class, disease/ disorder, services type, and region. In terms of drug class, the antibiotics segment is anticipated accounted for the largest share of the market in 2017 and its share is projected to increase by 2026. Antibiotics are extensively utilized, particularly for pediatric patients, due to their efficacy in treating bacterial infections. Based on disease/disorder, the allergy and respiratory segment is expected to account for a large share of the market. The segment is projected to expand at a CAGR more than 4.5% during the forecast period. Expansion of the segment can be attributed to the rise in demand for pediatric health care products for allergy and respiratory disorders. Among pediatric services types, the others services segment includes communicable diseases, non-communicable diseases, neonetal disorders, respiratory disorders, neurosurgical, and musculoskeletal services is expected to dominate the market. The others segment is expected to account for more than 60% share of the market by 2026.
Based on region, North America accounted for a dominant share of the global pediatric health care products and services market in 2017. The region accounted for a substantial share of the market due to launch of new drugs by pharmaceutical companies for pediatric patients in the region. The market in Asia Pacific is projected to expand at a considerable growth rate during the forecast period due to the increase in number of children with diseases and disorders and improvement in the health care infrastructure in countries such as China, India, and Indonesia.
Key players operating in the market include Pfizer Inc., GlaxoSmithKline plc. Merck & Co., Inc, AstraZeneca plc., Boehringer Ingelheim GmbH, Gilead Sciences, Inc., Sanofi S.A., Pediapharm, Inc., Novartis AG, Eisai Co., Ltd., and Mylan N.V. These players focus on R&D activities to develop and launch innovative product line in the market. For instance, in July 2017, Eisai Co., Ltd. received the U.S. Food and Drug Administration approval for its new product Fycompa, used to treat partial-onset seizures (POS). Moreover, in January 2017, Pediapharm, Inc. launched Rupall for the symptomatic relief of nasal and non-nasal symptoms of seasonal allergic rhinitis.
The global pediatric health care products and services market is segmented as given below:
|
Drug Class |
|
|
Disease/Disorder |
|
|
Services |
|
|
Region |
|
Interested in this report?
Get a FREE Brochure now!
*Get Brochure Report (PDF) sent to your email within minutes
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Pediatric Health Care Products and Services Market
4. Market Overview
4.1. Introduction
4.1.1. Disorder/Disease Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, 2016–2026
4.4.1. Market Revenue Projections, by Product Type (US$ Mn)
4.4.2. Market Revenue Projections, by Services Type (US$ Mn)
5. Market Overview
5.1. Clinical Trial Analysis
5.2. Disease Incidence and Prevalence
5.3. Regulatory Framework
6. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Disorder/Disease
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast by Disorder/Disease, 2016–2026
6.3.1. Allergy and Respiratory
6.3.2. Cancer
6.3.3. Cardiovascular
6.3.4. Central Nervous System
6.3.5. Gastrointestinal
6.3.6. Hormonal Imbalance
6.3.7. Infections
6.3.8. Others
6.4. Market Attractiveness by Disorder/Disease
7. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Drug Class
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast by Drug Class, 2016–2026
7.3.1. Antibiotics
7.3.2. Analgesics
7.3.3. Anti-asthmatics
7.3.4. Antidepressants
7.3.5. Antidiarrheal
7.3.6. Antifungal
7.3.7. Anti-histamines
7.3.8. Antihypertensives
7.3.9. Anti-metabolites
7.3.10. Anti-neoplastic Antibiotics
7.3.11. Antipsychotics
7.3.12. Others
8. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Services
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast by Services, 2016–2026
8.3.1. Child Psychiatry Services
8.3.2. Gastrointestinal Services
8.3.3. Pediatric Cancer Services
8.3.4. Pediatric Diabetes Services
8.3.5. Pediatric Heart Services
8.3.6. Others
9. Global Pediatric Health Care Products and Services Market Analysis and Forecasts, by Region
9.1. Key Findings
9.2. Market Value Forecast by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness by Country/Region
10. North America Pediatric Health Care Products and Services Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast by Disorder/Disease, 2016–2026
10.2.1. Allergy and Respiratory
10.2.2. Cancer
10.2.3. Cardiovascular
10.2.4. Central Nervous System
10.2.5. Gastrointestinal
10.2.6. Hormonal Imbalance
10.2.7. Infections
10.2.8. Others
10.3. Market Value Forecast by Drug Class, 2016–2026
10.3.1. Antibiotics
10.3.2. Analgesics
10.3.3. Anti-asthmatics
10.3.4. Antidepressants
10.3.5. Antidiarrheal
10.3.6. Antifungal
10.3.7. Anti-histamines
10.3.8. Antihypertensives
10.3.9. Anti-metabolites
10.3.10. Anti-neoplastic Antibiotics
10.3.11. Antipsychotics
10.3.12. Others
10.4. Market Value Forecast by Services, 2016–2026
10.4.1. Child Psychiatry Services
10.4.2. Gastrointestinal Services
10.4.3. Pediatric Cancer Services
10.4.4. Pediatric Diabetes Services
10.4.5. Pediatric Heart Services
10.4.6. Others
10.5. Market Value Forecast by Country, 2016–2026
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Disorder/Disease
10.6.2. By Drug Class
10.6.3. By Services
10.6.4. By Country
11. Europe Pediatric Health Care Products and Services Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast by Disorder/Disease, 2016–2026
11.2.1. Allergy and Respiratory
11.2.2. Cancer
11.2.3. Cardiovascular
11.2.4. Central Nervous System
11.2.5. Gastrointestinal
11.2.6. Hormonal Imbalance
11.2.7. Infections
11.2.8. Others
11.3. Market Value Forecast by Drug Class, 2016–2026
11.3.1. Antibiotics
11.3.2. Analgesics
11.3.3. Anti-asthmatics
11.3.4. Antidepressants
11.3.5. Antidiarrheal
11.3.6. Antifungal
11.3.7. Anti-histamines
11.3.8. Antihypertensives
11.3.9. Anti-metabolites
11.3.10. Anti-neoplastic Antibiotics
11.3.11. Antipsychotics
11.3.12. Others
11.4. Market Value Forecast by Services, 2016–2026
11.4.1. Child Psychiatry Services
11.4.2. Gastrointestinal Services
11.4.3. Pediatric Cancer Services
11.4.4. Pediatric Diabetes Services
11.4.5. Pediatric Heart Services
11.4.6. Others
11.5. Market Value Forecast by Country, 2016–2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Disorder/Disease
11.6.2. By Drug Class
11.6.3. By Services
11.6.4. By Country
12. Asia Pacific Pediatric Health Care Products and Services Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast by Disorder/Disease, 2016–2026
12.2.1. Allergy and Respiratory
12.2.2. Cancer
12.2.3. Cardiovascular
12.2.4. Central Nervous System
12.2.5. Gastrointestinal
12.2.6. Hormonal Imbalance
12.2.7. Infections
12.2.8. Others
12.3. Market Value Forecast by Drug Class, 2016–2026
12.3.1. Antibiotics
12.3.2. Analgesics
12.3.3. Anti-asthmatics
12.3.4. Antidepressants
12.3.5. Antidiarrheal
12.3.6. Antifungal
12.3.7. Anti-histamines
12.3.8. Antihypertensives
12.3.9. Anti-metabolites
12.3.10. Anti-neoplastic Antibiotics
12.3.11. Antipsychotics
12.3.12. Others
12.4. Market Value Forecast by Services, 2016–2026
12.4.1. Child Psychiatry Services
12.4.2. Gastrointestinal Services
12.4.3. Pediatric Cancer Services
12.4.4. Pediatric Diabetes Services
12.4.5. Pediatric Heart Services
12.4.6. Others
12.5. Market Value Forecast by Country, 2016–2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Disorder/Disease
12.6.2. By Drug Class
12.6.3. By Services
12.6.4. By Country
13. Latin America Pediatric Health Care Products and Services Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast by Disorder/Disease, 2016–2026
13.2.1. Allergy and Respiratory
13.2.2. Cancer
13.2.3. Cardiovascular
13.2.4. Central Nervous System
13.2.5. Gastrointestinal
13.2.6. Hormonal Imbalance
13.2.7. Infections
13.2.8. Others
13.3. Market Value Forecast by Drug Class, 2016–2026
13.3.1. Antibiotics
13.3.2. Analgesics
13.3.3. Anti-asthmatics
13.3.4. Antidepressants
13.3.5. Antidiarrheal
13.3.6. Antifungal
13.3.7. Anti-histamines
13.3.8. Antihypertensives
13.3.9. Anti-metabolites
13.3.10. Anti-neoplastic Antibiotics
13.3.11. Antipsychotics
13.3.12. Others
13.4. Market Value Forecast by Services, 2016–2026
13.4.1. Child Psychiatry Services
13.4.2. Gastrointestinal Services
13.4.3. Pediatric Cancer Services
13.4.4. Pediatric Diabetes Services
13.4.5. Pediatric Heart Services
13.4.6. Others
13.5. Market Value Forecast by Country, 2016–2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Disorder/Disease
13.6.2. By Drug Class
13.6.3. By Services
13.6.4. By Country
14. Middle East & Africa Pediatric Health Care Products and Services Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast by Disorder/Disease, 2016–2026
14.2.1. Allergy and Respiratory
14.2.2. Cancer
14.2.3. Cardiovascular
14.2.4. Central Nervous System
14.2.5. Gastrointestinal
14.2.6. Hormonal Imbalance
14.2.7. Infections
14.2.8. Others
14.3. Market Value Forecast by Drug Class, 2016–2026
14.3.1. Antibiotics
14.3.2. Analgesics
14.3.3. Anti-asthmatics
14.3.4. Antidepressants
14.3.5. Antidiarrheal
14.3.6. Antifungal
14.3.7. Anti-histamines
14.3.8. Antihypertensives
14.3.9. Anti-metabolites
14.3.10. Anti-neoplastic Antibiotics
14.3.11. Antipsychotics
14.3.12. Others
14.4. Market Value Forecast by Services, 2016–2026
14.4.1. Child Psychiatry Services
14.4.2. Gastrointestinal Services
14.4.3. Pediatric Cancer Services
14.4.4. Pediatric Diabetes Services
14.4.5. Pediatric Heart Services
14.4.6. Others
14.5. Market Value Forecast by Country, 2016–2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Israel
14.5.4. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Disorder/Disease
14.6.2. By Drug Class
14.6.3. By Services
14.6.4. By Country
15. Competition Landscape
15.1. Market Player – Competition Matrix (by Tier and Size of companies)
15.2. Company Profiles
15.2.1. AstraZeneca plc
15.2.1.1. Overview (HQ, Employee Strength, Business Segments)
15.2.1.2. Financials
15.2.1.3. Recent Development
15.2.1.4. Strategy
15.2.2. Boehringer Ingelheim GmbH
15.2.2.1. Overview (HQ, Employee Strength, Business Segments)
15.2.2.2. Financials
15.2.2.3. Recent Development
15.2.2.4. Strategy
15.2.3. Eisai Co., Ltd.
15.2.3.1. Overview (HQ, Employee Strength, Business Segments)
15.2.3.2. Financials
15.2.3.3. Recent Development
15.2.3.4. Strategy
15.2.4. Gilead Sciences, Inc.
15.2.4.1. Overview (HQ, Employee Strength, Business Segments)
15.2.4.2. Financials
15.2.4.3. Recent Development
15.2.4.4. Strategy
15.2.5. GlaxoSmithKline plc
15.2.5.1. Overview (HQ, Employee Strength, Business Segments)
15.2.5.2. Financials
15.2.5.3. Recent Development
15.2.5.4. Strategy
15.2.6. Merck & Co., Inc.
15.2.6.1. Overview (HQ, Employee Strength, Business Segments)
15.2.6.2. Financials
15.2.6.3. Recent Development
15.2.6.4. Strategy
15.2.7. Mylan N.V.
15.2.7.1. Overview (HQ, Employee Strength, Business Segments)
15.2.7.2. Financials
15.2.7.3. Recent Development
15.2.7.4. Strategy
15.2.8. Novartis AG
15.2.8.1. Overview (HQ, Employee Strength, Business Segments)
15.2.8.2. Financials
15.2.8.3. Recent Development
15.2.8.4. Strategy
15.2.9. Pediapharm, Inc.
15.2.9.1. Overview (HQ, Employee Strength, Business Segments)
15.2.9.2. Financials
15.2.9.3. Recent Development
15.2.9.4. Strategy
15.2.10. Pfizer Inc.
15.2.10.1. Overview (HQ, Employee Strength, Business Segments)
15.2.10.2. Financials
15.2.10.3. Recent Development
15.2.10.4. Strategy
15.2.11. Sanofi S.A.
15.2.11.1. Overview (HQ, Employee Strength, Business Segments)
15.2.11.2. Financials
15.2.11.3. Recent Development
15.2.11.4. Strategy
List of Tables
Table 01: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 02: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 03: Global Pediatric Health Care Products and Services Market Size (US$ Mn) Forecast, by Service Type, 2016–2026
Table 04: Global Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 05: Global Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 06: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 07: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 08: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 09: North America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 10: North America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Service type, 2016–2026
Table 11: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 12: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 13: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 14: Europe Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 15: Europe Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Services Type, 2016–2026
Table 16: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 17: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 18: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 19: Asia Pacific Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 20: Asia Pacific Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Services Type, 2016–2026
Table 21: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 22: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 23: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 24: Latin America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 25: Latin America Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Service Type, 2016–2026
Table 26: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 27: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Drug Class, 2016–2026
Table 28: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast, by Disorder/Disease, 2016–2026
Table 29: Middle East & Africa Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 30: Middle East & Africa Pediatric Health Care Services Market Size (US$ Mn) Forecast, by Service Type, 2016–2026
List of Figures
Figure 01: Global Pediatric Health Care Products Market Size (US$ Mn) Forecast, 2018–2026
Figure 02: Global Pediatric Health Care Services Market Size (US$ Mn) Forecast, 2018–2026
Figure 03: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Disorder/Disease, 2017 and 2026
Figure 04: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Allergy and Respiratory Market Revenue, 2016–2026
Figure 05: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Cancer Market Revenue, 2016–2026
Figure 06: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Cardiovascular Market Revenue, 2016–2026
Figure 07: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Central Nervous System Market Revenue, 2016–2026
Figure 08: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Gastrointestinal Market Revenue, 2016–2026
Figure 09: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Hormonal Imbalance Market Revenue, 2016–2026
Figure 10: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Infections Market Revenue, 2016–2026
Figure 11: Global Pediatric Health Care Products and Services Market Size (US$ Mn) and Y-o-Y Growth, by Others Market Revenue, 2016–2026
Figure 12: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Disorder/Disease
Figure 13: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Drug Class, 2017 and 2026
Figure 14: Global Antibiotics Market Revenue, US$ Mn, 2018–2026
Figure 15: Global Analgesics Market Revenue, US$ Mn, 2018–2026
Figure 16: Global Anti-asthmatics Market Revenue, US$ Mn, 2018–2026
Figure 17: Global Antidepressants Market Revenue, US$ Mn, 2018–2026
Figure 18: Global Antidiarrheal Market Revenue, US$ Mn, 2018–2026
Figure 19: Global Antifungal Market Revenue, US$ Mn, 2018–2026
Figure 20: Global Anti-histamines Market Revenue, US$ Mn, 2018–2026
Figure 21: Global Antihypertensives Market Revenue, US$ Mn, 2018–2026
Figure 22: Global Anti-metabolites Market Revenue, US$ Mn, 2018–2026
Figure 23: Global Anti-neoplastic Antibiotics Market Revenue, US$ Mn, 2018–2026
Figure 24: Global Antipsychotics Market Revenue, US$ Mn, 2018–2026
Figure 25: Global Other Drug Class Market Revenue, US$ Mn, 2018–2026
Figure 26: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Drug Class
Figure 27: Global Pediatric Health Care Products and Services Market Value Share Analysis, by Service Type, 2017 and 2026
Figure 28: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Child Psychiatry Services, 2018–2026
Figure 29: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Gastrointestinal Services, 2018–2026
Figure 30: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pediatric Cancer Services, 2018–2026
Figure 31: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pediatric Diabetes Services, 2018–2026
Figure 32: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Pediatric Heart Services, 2018–2026
Figure 33: Global Pediatric Health Care Products and Services Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2018–2026
Figure 34: Global Pediatric Health Care Products and Services Market Attractiveness Analysis, by Service Type
Figure 35: Global Pediatric Health Care Products Market Value Share Analysis, by Region, 2016 and 2025
Figure 36: Global Pediatric Health Care Products Market Attractiveness Analysis, by Region
Figure 37: Global Pediatric Health Care Services Market Value Share Analysis, by Region, 2016 and 2025
Figure 38: Global Pediatric Health Care Services Market Attractiveness Analysis, by Region
Figure 39: North America Pediatric Health Care Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 40: North America Pediatric Health Care Products Market Value Share, by Country, 2017 and 2026
Figure 41: North America Pediatric Health Care Products Market Attractiveness, by Country, 2018–2026
Figure 42: North America Pediatric Health Care Products Market Value Share, by Drug Class, 2017 and 2026
Figure 43: North America Pediatric Health Care Products Market Attractiveness, by Drug Class, 2018–2026
Figure 44: North America Pediatric Health Care Products Market Value Share Analysis, by Disorder/Disease
Figure 45: North America Pediatric Health Care Products Market Attractiveness, by Disorder/Disease, 2018–2026
Figure 46: North America Pediatric Health Care Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 47: North America Pediatric Health Care Services Market Value Share, by Country, 2017 and 2026
Figure 48: North America Pediatric Health Care Services Market Attractiveness, by Country, 2018–2026
Figure 49: North America Pediatric Health Care Services Market Value Share, by Service type, 2017 and 2026
Figure 50: North America Pediatric Health Care Services Market Attractiveness, by Service type, 2018–2026
Figure 51: Europe Pediatric Health Care Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 52: Europe Pediatric Health Care Products Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 53: Europe Pediatric Health Care Products Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 54: Europe Pediatric Health Care Products Market Value Share, by Drug Class, 2017 and 2026
Figure 55: Europe Pediatric Health Care Products Market Attractiveness, by Drug Class, 2018–2026
Figure 56: Europe Pediatric Health Care Products Market Value Share Analysis, by Disorder/Disease
Figure 57: Europe Pediatric Health Care Products Market Attractiveness, by Disorder/Disease, 2018–2026
Figure 58: Europe Pediatric Health Care Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 59: Europe Pediatric Health Care Services Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 60: Europe Pediatric Health Care Services Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 61: Europe Pediatric Health Care Services Market Value Share, by Services Type, 2017 and 2026
Figure 62: Europe Pediatric Health Care Services Market Attractiveness, by Services Type, 2018–2026
Figure 63: Asia Pacific Pediatric Health Care Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 64: Asia Pacific Pediatric Health Care Products Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 65: Asia Pacific Pediatric Health Care Products Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 66: Asia Pacific Pediatric Health Care Products Market Value Share, by Drug Class, 2017 and 2026
Figure 67: Asia Pacific Pediatric Health Care Products Market Attractiveness, by Drug Class, 2018–2026
Figure 68: Asia Pacific Pediatric Health Care Products Market Value Share Analysis, by Disorder/Disease
Figure 69: Asia Pacific Pediatric Health Care Products Market Attractiveness, by Disorder/Disease, 2018–2026
Figure 70: Asia Pacific Pediatric Health Care Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
Figure 71: Asia Pacific Pediatric Health Care Services Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 72: Asia Pacific Pediatric Health Care Services Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 73: Asia Pacific Pediatric Health Care Services Market Value Share, by Services Type, 2017 and 2026
Figure 74: Asia Pacific Pediatric Health Care Services Market Attractiveness, by Services Type, 2018–2026
Figure 75: Latin America Pediatric Health Care Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 76: Latin America Pediatric Health Care Products Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 77: Latin America Pediatric Health Care Products Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 78: Latin America Pediatric Health Care Products Market Value Share, by Drug Class, 2017 and 2026
Figure 79: Latin America Pediatric Health Care Products Market Attractiveness, by Drug Class, 2018–2026
Figure 80: Latin America Pediatric Health Care Products Market Value Share Analysis, by Disorder/Disease
Figure 81: Latin America Pediatric Health Care Products Market Attractiveness, by Disorder/Disease, 2018–2026
Figure 82: Latin America Pediatric Health Care Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 83: Latin America Pediatric Health Care Services Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 84: Latin America Pediatric Health Care Services Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 85: Latin America Pediatric Health Care Services Market Value Share, by Service Type, 2017 and 2026
Figure 86: Latin America Pediatric Health Care Services Market Attractiveness, by Service Type, 2018–2026
Figure 87: Middle East & Africa Pediatric Health Care Products Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 88: Middle East & Africa Pediatric Health Care Products Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 89: Middle East & Africa Pediatric Health Care Products Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 90: Middle East & Africa Pediatric Health Care Products Market Value Share, by Drug Class, 2017 and 2026
Figure 91: Middle East & Africa Pediatric Health Care Products Market Attractiveness, by Drug Class, 2018–2026
Figure 92: Middle East & Africa Pediatric Health Care Products Market Value Share Analysis, by Disorder/Disease
Figure 93: Middle East & Africa Pediatric Health Care Products Market Attractiveness, by Disorder/Disease, 2018–2026
Figure 94: Middle East & Africa Pediatric Health Care Services Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2016–2026
Figure 95: Middle East & Africa Pediatric Health Care Services Market Value Share, by Country, 2017 and 2026
Figure 96: Middle East & Africa Pediatric Health Care Services Market Attractiveness, by Country, 2018–2026
Figure 97: Middle East & Africa Pediatric Health Care Services Market Value Share, by Service Type, 2017 and 2026
Figure 98: Middle East & Africa Pediatric Health Care Services Market Attractiveness, by Service Type, 2018–2026
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
